ACB on Nasdaq

Aurora Cannabis

Canadian cannabis company

Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

1.6MNet income, fiscal 20254
2013Founded1

Compare with Canopy Growth Corporation, IM Cannabis Corp. or SNDL Inc., or pick any stock.

  • TickerACB on Nasdaq1
  • Industrycannabis industry1
  • HeadquartersEdmonton1
  • Websiteauroramj.com
  • Incorporated inBritish Columbia, Canada5
  • Business address2207 90B Street Sw, Edmonton, A0 T6X 1V85
  • Filer category, Emerging growth company5

See how the biggest companies compare on our leaderboards

AuroraSky
Photo: Khoshhat, CC BY-SA 4.0, via Wikimedia Commons6

Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CAD, the currency the company reports in.

Key numbers, fiscal 2022

9.6%Gross margin7
-104.6%Operating margin7
-776.2%Net margin7
-9.8%Revenue growth, 20227
-258.0%Return on equity8
-142.5M CADFree cash flow7

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Other costs100¢221.3M CAD

Out of 221.3M CAD in revenue.7 The company lost money this year.

Financial statements

Revenue91011127221.3M CAD in 2022+301% since 2018
0100.0M CAD200.0M CAD300.0M CAD2018: 55.2M CAD55.2M CAD20182019: 245.5M CAD245.5M CAD2019+345%2020: 268.7M CAD268.7M CAD2020+9%2021: 245.3M CAD245.3M CAD2021−9%2022: 221.3M CAD221.3M CAD2022−10%
Gross profit9101112721.2M CAD in 2022−51% since 2018
-50.0M CAD050.0M CAD100.0M CAD150.0M CAD2018: 43.5M CAD43.5M CAD20182019: 142.4M CAD142.4M CAD2019+227%2020: -19.9M CAD-19.9M CAD20202021: -21.6M CAD-21.6M CAD2021+8%2022: 21.2M CAD21.2M CAD2022
Operating income91011127-231.4M CAD in 2022+142% since 2018
-600.0M CAD-400.0M CAD-200.0M CAD02018: -95.8M CAD-95.8M CAD20182019: -318.3M CAD-318.3M CAD2019+232%2020: -465.8M CAD-465.8M CAD2020+46%2021: -282.8M CAD-282.8M CAD2021−39%2022: -231.4M CAD-231.4M CAD2022−18%
Net income91011127-1.7B CAD in 2022
-4.0B CAD-3.0B CAD-2.0B CAD-1.0B CAD01.0B CAD2018: 69.2M CAD69.2M CAD20182019: -300.6M CAD-300.6M CAD20192020: -3.3B CAD-3.3B CAD2020+1001%2021: -695.1M CAD-695.1M CAD2021−79%2022: -1.7B CAD-1.7B CAD2022+147%

Every line of the income statement in the latest annual report, as filed.13

Period ending2026-03-312025-03-31
Revenue342.4M CAD319.9M CAD
Excise taxes-21.8M CAD-30.9M CAD
Net revenue320.6M CAD288.9M CAD
Cost of sales161.8M CAD144.1M CAD
Gross profit before fair value adjustments158.8M CAD144.8M CAD
Loss on changes in fair value of inventory and biological assets sold138.3M CAD132.0M CAD
Gain on changes in fair value of biological assets-116.1M CAD-168.1M CAD
Gross profit (loss)136.7M CAD181.0M CAD
General and administration106.6M CAD91.3M CAD
Sales and marketing59.6M CAD56.2M CAD
Business development costs2.0M CAD3.4M CAD
Research and development4.0M CAD3.7M CAD
Depreciation and amortization3.8M CAD3.0M CAD
Share-based compensation7.3M CAD12.9M CAD
Operating expenses183.3M CAD170.5M CAD
Interest and other income5.8M CAD10.3M CAD
Finance and other costs-1.8M CAD-2.5M CAD
Foreign exchange gain (loss)1.3M CAD11.7M CAD
Other gains (losses)720.0K CAD2.1M CAD
Impairment of property, plant and equipment-2.8M CAD-696.0K CAD
Impairment of intangible assets and goodwill-13.2M CAD0 CAD
Other income (expenses)-9.9M CAD20.9M CAD
Income (loss) before income tax recovery (expense)-56.5M CAD31.3M CAD
Current-2.0M CAD-7.4M CAD
Deferred, net-55.0K CAD3.2M CAD
Income tax recovery (expense)-2.1M CAD-4.2M CAD
Net income (loss) from continuing operations-58.6M CAD27.1M CAD
Net loss from discontinued operations, net of tax-77.3M CAD-25.5M CAD
Net income (loss)-136.0M CAD1.6M CAD
Foreign currency translation gain (loss)1.6M CAD-9.2M CAD
Total other comprehensive income (loss)1.6M CAD-9.2M CAD
Comprehensive income (loss) from continuing operations-57.0M CAD17.9M CAD
Comprehensive income (loss) from discontinued operations-77.3M CAD-25.5M CAD
Comprehensive income (loss)-134.3M CAD-7.6M CAD
Aurora Cannabis Inc.-58.6M CAD27.1M CAD
Non-controlling interests0 CAD0 CAD
Aurora Cannabis Inc.-63.1M CAD-24.8M CAD
Non-controlling interests-14.2M CAD-677.0K CAD
Aurora Cannabis Inc.-120.1M CAD-6.9M CAD
Non-controlling interests-14.2M CAD-677.0K CAD
Basic, continuing operations (in CAD per share)-1.03 CAD0.49 CAD
Basic, discontinued operations (in CAD per share)-1.11 CAD-0.45 CAD
Basic income (loss) per share (in CAD per share)-2.14 CAD0.04 CAD
Diluted, continuing operations (in CAD per share)-1.03 CAD0.49 CAD
Diluted, discontinued operations (in CAD per share)-1.11 CAD-0.45 CAD
Diluted income (loss) per share (in CAD per share)-2.14 CAD0.04 CAD

Compare Aurora Cannabis with another company

How it started

History

Aurora was founded in 2006 by Terry Booth, Steve Dobler, Dale Lesack and Chris Mayerson. Booth and Dobler collectively invested over $5 million of their own capital. The founding group secured a 160+ acre parcel of land in Mountain View County, Alberta, where they established Aurora's first facility. The company received its license to grow cannabis in 2014, making it the first cannabis producer to obtain a federal license in that province. They decided to establish the company in Alberta due to comparatively low corporate tax rates and an ideal farm credit program. On November 27, 2014, Health Canada issued Aurora's first license to sell medical cannabis. Since then they have built, and are operating, numerous growing facilities throughout Canada, Europe, Asia, Latin America and Oceania. On January 10, 2017, Aurora received a license from Health Canada to sell cannabis oils, having been granted a license to produce the oils in February 2016. Sales of four product lines of cannabis oils commenced in April, 2017.

After legalization in Canada - October 2018

Canada legalized the retail sale of cannabis nationally on October 17, 2018. Due to its significant capital investments, particularly in large growing facilities, Aurora had about 20% of the Canadian retail market for cannabis during early 2019.

At its year-end in June 2019, Aurora had a market capitalization of US$4.8 billion. An October 2019 report stated that cannabis stocks had "crumbled to their lowest level since 2017"; Aurora shares were also at a two-year low. The fall in stock price for Aurora and other Canadian cannabis stocks in late 2019 was attributed to the missed benchmark revenues, general lack of profitability in the industry, slow rollout of retail stores in Canada, rise in vaping-related illnesses, non-competitiveness of pricing with black market cannabis, oversupply of commercial cannabis, termination of capital expenditures, and an FDA warning that cannabidiol may cause liver injury, among others.

Public trading and acquisitions

From Wikipedia’s article on Aurora Cannabis, shared under CC BY-SA 4.0.3

Timeline

  1. 2013Founded Founded1

Recent filings

  1. Oct 14, 20266-K
  2. Oct 8, 20266-K
  3. Oct 7, 20266-K
  4. Oct 6, 20266-K
  5. Oct 6, 2026SC14D9F/A
  6. Oct 6, 2026SC14D9F/A
  7. Sep 24, 20266-K
  8. Sep 24, 2026SC14D9F/A
  9. Sep 16, 20266-K
  10. Sep 14, 20266-K
  11. Sep 14, 2026SC14D9F/A
  12. Sep 9, 20266-K
  13. Sep 2, 2026SC14D9F
  14. Sep 2, 2026F-X
  15. Sep 2, 20266-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13